0521779407-14 CUNY1086/Karliner 0 521 77940 7 June 4, 2007 21:16
988 Mineralocorticoid Disorders
➣Cushing’s syndrome (esp. associated with ectopic ACTH)
➣Congenital adrenal hyperplasia
➣Barter’s syndrome
➣Gittelman’s syndrome
➣Renovascular or malignant hypertension
➣Diuretics, diarrhea, vomiting
➣CHF, nephrotic syndrome, cirrhosis
➣Inhibitors of 11-beta-hydroxysteroid dehydrogenase II (e.g., car-
benoxone, licorice)
■Mineralocorticoid deficiency:
➣Primary hypoaldosteronism; heparin-induced
➣Congenital adrenal hyperplasia
➣Primary adrenal insufficiency
➣Chronic interstitial nephritis with mild renal insufficiency
➣Renal failure
➣Medications: NSAIDs, ACE inhibitors, cyclosporine, amiloride,
spironolactone, triamterene, trimethoprim, pentamidine
➣Pseudohypoaldosteronism
management
What to Do First
■Normalize serum potassium
■Discontinue confounding medications
General Measures
■Exclude common causes
■Evaluate laboratory data in context of dietary salt intake
■Use PRA to distinguish primary vs secondary disorders
■Confirm, establish cause
■Treat hypertension
■Restrict salt in mineralocorticoid excess
■Liberalize salt in mineralocorticoid deficiency
specific therapy
■Mineralocorticoid excess: amiloride, spironolactone, triamterene;
dexamethasone for glucocorticoid-remediable hyperaldosteronism
(rare); surgery indicated for unilateral adenoma
■Mineralocorticoid deficiency: thiazide or furosemide for mild sec-
ondary causes; fludrocortisone
■Side Effects & Contraindications
➣Mineralocorticoid excess: hyperkalemia, gynecomastia, impo-
tence, rash, liver function abnormalities